Azacytidine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 5-AZC, 5-aza, 5-azacytidine, AZA-CR, Ladakamycin, NSC-102816, Vidaza™

Filter by location:

Houston, Texas1 trial

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

MD Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.